Alere is withdrawing the Alere INRatio and INRatio 2 prothrombin time (PT) monitoring systems (professional use and patient self-test) devices from the Canadian market. There is a risk, in certain cases, that the Alere devices provide an inaccurate low reading. Alere, with the best interest of patient safety in mind, has decided to voluntarily remove the Alere INRatio system from the market and to discontinue manufacturing the product line. Alere will continue manufacturing and distributing the INRatio test strips for a period of time to allow patients to safely transition to another monitoring method. Alere advises that users of the INRatio system transition, as soon as possible, to an alternate method to perform PT/INR testing, such as a plasma-based laboratory INR or a point of care monitoring system from a different manufacturer. Until such time that a facility has transitioned to an alternate method of PT/INR testing, they may continue to use the Alere INRatio system as long as they ensure that the facility and their patients (either patients being tested at their facility or their patients who self-test at home) adhere to the precautions and recommendations found in the medical device correction notification of December 2014 and current product insert labeling. These are available at www.inr-care.com or by calling Alere at 1-877-866-5313.